Diabetes Infographic: Real-time Patient Insights from Medisafe
Highlights from the Diabetes Infographic
- The frequency of dosing schedules in both the GLP-1 class and Insulin impacts the rate of adherence
- 71% of Medisafe users improved their adherence after adding a Medisafe Medfriend who is alerted each time a dose is missed
- 17% improvement of average reported adherence rate a after adding a Medifriend
What insights can we discover about your brand? Contact us to find out!
Full Diabetes Adherence Insights
Reported Diabetes Drug Adherence by Drug & Dose
- GLP-1, 1x/week: 88%
- GLP-1, 1x/day: 80%
- GLP-1, 2x/day: 77%
- Insulin, Long-acting 1-2x/day: 79%
- Insulin, Intermediate-acting 1-2x/day: 78%
- Insulin, Short-acting 2-3x/day: 73%
- Insulin, Rapid-acting 3x/day: 73%
Injectables versus Orals
- All GLP-1 and insulin injectables: 76%
- All oral diabetic meds: 74%